gastric sleeve and semaglutide Ozempic or Bariatric Surgery: Which Option Is Best? The Potential of Semaglutide Once-Weekly
Description
Read Pienomial's insights on this key clinical development for diabetes.
Leading Players in the GLP-1 Market Novo Nordisk 38.72% Ozempic Wegovy Rybelsus Eli Lilly 28.41% Mounjaro Zepbound Sanofi 8.76% 4 AstraZeneca 6.62% 5 GSK 4.95% 6 Regeneron 3.27% 7 Pfizer 2.61% 8 Amgen 1.98% 9 Sun Pharma 1.52% Boehringer Ingelheim 1.24% Together, Novo Nordisk and Eli Lilly account for more than 67% of the market, highlighting the intense competition between the two companies that currently lead the obesity and diabetes treatment revolution
Achieve sustainable weight loss with our Semaglutide Home Kit
With semaglutide's patent set to expire in January 2026, Indian pharmaceutical leaders like Biocon, Dr
The results of the IPTW and subgroup analyses confirmed those of the main analysis
